HAPLN3 and prostate cancer: The mentioned studies analyzed prostate cancer tissues; however, the HAPLN3 DNA methylation from prostate cancer patients’ circulating tumor DNA was also shown to be a part of the three methylated gene signature with potential role in prostate cancer diagnosis and risk stratification [481].